Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (861-870 of 1,212) with videos related to

Pageof 122
Sort By:
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
JAMA Cardiology|July 21, 2016
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical TrialZiad Hijazi, Stefan H Hohnloser, Ulrika Andersson, et al.
Journal of Internal Medicine|May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trialH Røsjø, Z Hijazi, T Omland, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgeryRajendra H Mehta, Gail E Hafley, C Michael Gibson, et al.
European Heart Journal Open|November 30, 2023
The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery-Extended Follow-Up study (PALACS-EF): rationale and designMario Gaudino, Lamia Harik, Bjorn Redfors, et al.
British Journal of Pharmacology|May 3, 2020
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29Steve P H Alexander, Jane F Armstrong, Anthony P Davenport, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
Occupational and Environmental Medicine|November 23, 2025
Low-dose occupational ionising radiation exposure and gastrointestinal cancer mortality among US radiologic technologists, 1983-2021Jim Z Mai, Raquel Velazquez-Kronen, Martha S Linet, et al.
Radiation Research|August 24, 2010
Radiation Organ Doses Received by U.S. Radiologic Technologists: Estimation Methods and FindingsSteven L Simon, Robert M Weinstock, Michele Morin Doody, et al.
American Heart Journal|December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialChristopher B Granger, Renato D Lopes, Michael Hanna, et al.
Pageof 122

Showing results (861-870 of 1,212) with videos related to

Sort By:
Pageof 122
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
JAMA Cardiology|July 21, 2016
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical TrialZiad Hijazi, Stefan H Hohnloser, Ulrika Andersson, et al.
Journal of Internal Medicine|May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trialH Røsjø, Z Hijazi, T Omland, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgeryRajendra H Mehta, Gail E Hafley, C Michael Gibson, et al.
European Heart Journal Open|November 30, 2023
The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery-Extended Follow-Up study (PALACS-EF): rationale and designMario Gaudino, Lamia Harik, Bjorn Redfors, et al.
British Journal of Pharmacology|May 3, 2020
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29Steve P H Alexander, Jane F Armstrong, Anthony P Davenport, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
Occupational and Environmental Medicine|November 23, 2025
Low-dose occupational ionising radiation exposure and gastrointestinal cancer mortality among US radiologic technologists, 1983-2021Jim Z Mai, Raquel Velazquez-Kronen, Martha S Linet, et al.
Radiation Research|August 24, 2010
Radiation Organ Doses Received by U.S. Radiologic Technologists: Estimation Methods and FindingsSteven L Simon, Robert M Weinstock, Michele Morin Doody, et al.
American Heart Journal|December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialChristopher B Granger, Renato D Lopes, Michael Hanna, et al.
Pageof 122